Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Medizone International Inc

+ Add to Watchlist


0.083 EUR 0.0000.00%

As of 13:21:37 ET on 03/05/2015.

Snapshot for Medizone International Inc (NCK)

Open: - Day's Range: - Volume: 0
Previous Close: 0.083 52wk Range: 0.066 - 0.210 1-Yr Rtn: -27.83%

Stock Chart for NCK

No chart data available.
  • NCK:GR 0.083
  • 1D
  • 1M
  • 1Y
Interactive NCK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NCK

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 28.75
Shares Outstanding (M) 346.33
30 Day Average Volume 100
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NCK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NCK

Medizone International, Inc. researches and develops ozone based treatment for diseases and health problems caused by lipid enveloped viruses such as Hepa- titus B. The Company is also developing technology for the decontamination of blood, blood products, and veterinarian serum products.

Edwin G MarshallChairman/CEOMichael E ShannonPresident/Dir:Medical Affairs
Thomas E Auger "Tommy"Chief Financial Officer
More Company Profile & Key Executives for NCK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil